Carrageenan Nasal Spray for COVID-19 Prophylaxis

NACompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

December 17, 2020

Primary Completion Date

November 18, 2022

Study Completion Date

November 18, 2022

Conditions
COVID-19SARS-CoV 2
Interventions
DEVICE

Carrageenan nasal and throat spray

Iota-carrageenan nasal and throat spray (verum Coldamaris plus i.e. Iota-Carrageenan 0.12% plus 0.04% Kappa-Carrageenan in 0.5% saline)

DEVICE

Saline nasal and throat spray

Saline nasal and throat spray (placebo Coldamaris sine i.e. 0.5% saline)

Trial Locations (1)

SA6 6NL

Joint Clinical Research Facility, Swansea

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cardiff University

OTHER

collaborator

Marinomed Biotech AG

INDUSTRY

collaborator

Walgreens Boots Alliance

OTHER

collaborator

Abertawe Bro Morgannwg University Health Board

OTHER

lead

Swansea University

OTHER

NCT04590365 - Carrageenan Nasal Spray for COVID-19 Prophylaxis | Biotech Hunter | Biotech Hunter